Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making.

Peng H, Jiang J, Wang Z, Wang W

Open source

DOI
10.1186/s13048-026-02201-y
Published
2026 Jul 21
Container
Journal of ovarian research
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13048-026-02201-y,
  title = {Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making.},
  author = {Peng H and Jiang J and Wang Z and Wang W},
  year = {2026},
  journal = {Journal of ovarian research},
  doi = {10.1186/s13048-026-02201-y},
  url = {https://doi.org/10.1186/s13048-026-02201-y}
}

RIS

TY  - JOUR
TI  - Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making.
AU  - Peng H
AU  - Jiang J
AU  - Wang Z
AU  - Wang W
PY  - 2026
JO  - Journal of ovarian research
DO  - 10.1186/s13048-026-02201-y
UR  - https://doi.org/10.1186/s13048-026-02201-y
ER  - 

APA

H, P., J, J., Z, W., & W, W. (2026). Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making.. Journal of ovarian research. https://doi.org/10.1186/s13048-026-02201-y

Source records